Researchers at UCLA and NIH have discovered a new compound that can block viruses from entering cells, providing potential relief for conditions like HIV, herpes, and the flu. The compound also shows promise in combating antibiotic-resistant bacteria.
Researchers have found that Clioquinol, an old antibiotic, may interrupt the production of mutant huntingtin protein in neurons, reducing its toxic effects and potentially slowing down Huntington's disease progression. The study suggests a new potential treatment for the degenerative brain disorder.
Researchers identified a rare syndrome resulting from a HOXA1 gene mutation, affecting horizontal eye movement, hearing, motor skills, and cardiovascular development. The study provides new insights into the role of HOXA1 in human brain development and may lead to ongoing research directions in developmental biology.
eEF1A2 protein is moderately to highly expressed in two-thirds of breast tumor cells, with significant over-expression in estrogen receptor-positive tumors. The protein's role in breast tumour development remains unclear, but may be related to its function in protein synthesis or cytoskeletal remodelling.
Researchers found that older adults' brains have trouble filtering out distracting information, leading to memory impairment. The study provides a new diagnostic tool for attention and memory problems in both young and old individuals.